These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6226124)

  • 1. Potentiation of thioacetamide-induced hepatotoxicity in alloxan- and streptozotocin-diabetic rats.
    El-Hawari AM; Plaa GL
    Toxicol Lett; 1983 Jul; 17(3-4):293-300. PubMed ID: 6226124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of carbon tetrachloride-induced hepatotoxicity in alloxan- or strepto- zotocin-diabetic rats.
    Hanasono GK; Côté MG; Plaa GL
    J Pharmacol Exp Ther; 1975 Mar; 192(3):592-604. PubMed ID: 164533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced hepatotoxicity and toxic outcome of thioacetamide in streptozotocin-induced diabetic rats.
    Wang T; Fontenot RD; Soni MG; Bucci TJ; Mehendale HM
    Toxicol Appl Pharmacol; 2000 Jul; 166(2):92-100. PubMed ID: 10896850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of thioacetamide on rat liver plasma membrane enzymes and its potentiation by fasting.
    Nikolaev V; Kerimova M; Naydenova E; Dimov S; Savov G; Ivanov E
    Toxicology; 1986 Feb; 38(2):203-8. PubMed ID: 3945971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of thioacetamide hepatotoxicity by phenobarbital pretreatment in rats. Inducibility of FAD monooxygenase system and age effect.
    Zaragoza A; Andrés D; Sarrión D; Cascales M
    Chem Biol Interact; 2000 Jan; 124(2):87-101. PubMed ID: 10670821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adrenocortical function of alloxan-induced diabetic rats.
    Lin JH; Shieh MH; Wu LS; Lin WH
    Proc Natl Sci Counc Repub China B; 1985 Apr; 9(2):97-102. PubMed ID: 2931740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced hepatotoxicity of carbon tetrachloride, thioacetamide, and dimethylnitrosamine by pretreatment of rats with ethanol and some comparisons with potentiation by isopropanol.
    Maling HM; Stripp B; Sipes IG; Highman B; Saul W; Williams MA
    Toxicol Appl Pharmacol; 1975 Aug; 33(2):291-308. PubMed ID: 1179434
    [No Abstract]   [Full Text] [Related]  

  • 8. 1,10 phenanthroline, a metal chelator, protects against alloxan- but not streptozotocin-induced diabetes.
    Eizirik DL; de Lúcio MA; Boschero AC; Hoffmann ME
    J Free Radic Biol Med; 1986; 2(3):189-92. PubMed ID: 3033047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verapamil induces protection of alloxan but not streptozotocin-induced diabetes in rats.
    Katsumata K; Miyao K; Katsumata Y
    Horm Metab Res; 1988 Jan; 20(1):65. PubMed ID: 2967238
    [No Abstract]   [Full Text] [Related]  

  • 10. Sensitivity of BB rat beta cells as determined by dose-responses to the cytotoxic effects of streptozotocin and alloxan.
    Yale JF; Grose M; Videtic GM; Marliss EB
    Diabetes Res; 1986 Mar; 3(3):161-7. PubMed ID: 2940045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of thioacetamide liver injury in diabetic rats is due to induced CYP2E1.
    Wang T; Shankar K; Ronis MJ; Mehendale HM
    J Pharmacol Exp Ther; 2000 Aug; 294(2):473-9. PubMed ID: 10900221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of NF-kappaB signaling in impaired liver tissue repair in thioacetamide-treated type 1 diabetic rats.
    Devi SS; Mehendale HM
    Eur J Pharmacol; 2005 Oct; 523(1-3):127-36. PubMed ID: 16246324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2 diabetic rats are sensitive to thioacetamide hepatotoxicity.
    Sawant SP; Dnyanmote AV; Warbritton A; Latendresse JR; Mehendale HM
    Toxicol Appl Pharmacol; 2006 Mar; 211(3):221-32. PubMed ID: 16153671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of retinyl palmitate on streptozotocin- and alloxan-induced beta cell toxicity and diabetes in the rat.
    Chertow BS; Webb MD; Leidy JW; Cordle MB
    Res Commun Chem Pathol Pharmacol; 1989 Jan; 63(1):27-44. PubMed ID: 2521747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloxan as a better option than streptozotocin for studies involving painful diabetic neuropathy.
    Rodrigues PV; Lemos BMS; Silva MVD; de Campos Lima T; Santos DO; Lemes JBP; Lotufo CMDC
    J Pharmacol Toxicol Methods; 2021; 112():107090. PubMed ID: 34175449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of diurnal rhythms on the hepatotoxicity of thioacetamide in male and female rats.
    Lawrence GM; Beesley AC
    Drug Metabol Drug Interact; 1988; 6(3-4):359-70. PubMed ID: 2482801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late preventive effects on dimethylnitrosamine, thioacetamide or galactosamine-induced liver necrosis of the inhibitor of proteases, phenylmethylsulfonyl fluoride.
    de Ferreyra EC; de Fenos OM; Castro JA
    Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):505-8. PubMed ID: 6665306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective role of superoxide dismutase against diabetogenic drugs.
    Gandy SE; Buse MG; Crouch RK
    J Clin Invest; 1982 Sep; 70(3):650-8. PubMed ID: 6213639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of thioacetamide-induced liver necrosis by prior administration of substrates of microsomal flavin-containing monooxygenase.
    De Ferreyra EC; De Fenos OM; Castro JA
    Toxicol Lett; 1983 Aug; 18(1-2):127-31. PubMed ID: 6623535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diallyl sulfide inhibition of CYP2E1 does not rescue diabetic rats from thioacetamide-induced mortality.
    Wang T; Shankar K; Bucci TJ; Warbritton A; Mehendale HM
    Toxicol Appl Pharmacol; 2001 May; 173(1):27-37. PubMed ID: 11350212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.